



Title: Nigral and striatal connectivity alterations in asymptomatic LRRK2 mutation 
carriers: a magnetic resonance imaging study. 
 
Authors: Dolores Vilas, MD1*, Bàrbara Segura, PhD2*, Hugo C. Baggio MD, PhD2, 
Claustre Pont-Sunyer, MD1, Yaroslau Compta, MD, PhD1,3,4, Francesc Valldeoriola, 
MD, PhD1,3,4, María José Martí, MD, PhD1,3,4, María Quintana, PhD1, Angels Bayés, 
MD5, Jorge Hernández-Vara, MD6, Matilde Calopa, MD7, Miquel Aguilar, MD8, 
Carme Junqué, MD, PhD2,3,4, Eduardo Tolosa, MD, PhD1,3,4 and the Barcelona 
LRRK2 Study Group9. 
* These authors contributed equally to the manuscript. 
 
Author’s affiliations:   
1Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, 
Barcelona, Catalonia, Spain. 2Psychiatry and Clinical Psychobiology Department, 
Universitat de Barcelona. Barcelona, Catalonia, Spain.  3Institut d'Investigacions 
Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain. 4Centro de 
Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas 
(CIBERNED), Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain. 5 
Parkinson’s Unit, Clínica Teknon, Barcelona, Spain. 6 Neurology Service, Hospital 
Universitari Vall D’Hebron, Barcelona, Catalonia, Spain. 7Neurology Service, 
Hospital Universitari de Bellvitge, Barcelona, Catalonia, Spain. 8Neurology Service, 
Hospital Universitari Mutua de Terrasa, Barcelona, Catalonia, Spain. 9Collaborators 
listed at end of manuscript. 
Corresponding author: Eduardo Tolosa, Neurology Service, Hospital Clínic 
Barcelona, C/Villarroel 170, 08036 Barcelona, Phone: +34 93 2275785, Fax: +34 93 




Conflict of interest: None of the authors of this manuscript report conflict of interest. 
Word count: 2945 
 
Running title: Functional connectivity in asymptomatic LRRK2 mutation carriers. 
 
Key words: LRRK2, Parkinson’s disease, functional MRI, connectivity. 
 
Funding sources: none. 
 
Email addresses of all authors:  
dvilas@clinic.ub.es, segura.barbara@gmail.com, hbaggio@ub.edu, 

















Abstract   
Background. The study of the functional connectivity by means of magnetic 
resonance imaging (MRI) in asymptomatic LRRK2 mutation carriers could contribute 
to the characterization of the prediagnostic phase of LRRK2 associated Parkinson’s 
disease (PD). 
Objective. To characterize MRI functional patterns during resting state in 
asymptomatic LRRK2 mutation carriers.  
Methods. We acquired structural and functional MRI data of 18 asymptomatic 
LRRK2 mutation carriers and 18 asymptomatic LRRK2 mutation noncarriers, all first-
degree relatives of LRRK2-PD patients. Starting from resting state data, we analyzed 
the functional connectivity of the striatocortical and the nigrocortical circuitry. 
Structural brain data was analyzed by voxel based morphometry, cortical thickness 
and volumetric measures. 
Results: Asymptomatic LRRK2 mutation carriers had functional connectivity 
reductions between the caudal motor part of the left striatum and ipsilateral precuneus 
and superior parietal lobe. Connectivity in these regions correlated with subcortical 
gray matter volumes in mutation carriers. Asymptomatic carriers also showed 
increased connectivity between the right substantia nigra and bilateral occipital 
cortical regions (occipital pole and cuneus bilaterally, and right lateral occipital 
cortex). No intergroup differences in structural MRI measures were found.  In LRRK2 
mutation carriers, age and functional connectivity correlated negatively with striatal 
volumes. Additional analyses including only subjects with the G2019S mutation 
revealed similar findings.   
Conclusion: Asymptomatic LRRK2 mutation carriers showed functional connectivity 




findings support the concept that altered brain connectivity precedes the onset of 





Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) are the most common 
known cause of inherited Parkinson’s disease (PD). Potential disease modification 
treatments for LRRK2-PD, such as LRRK2 kinase inhibitors, are currently under 
intense study1. If effective, it is hoped that these treatments could also have a positive 
effect in sporadic PD cases since LRRK2-PD is clinically similar to sporadic PD and 
responds to the same therapies. 
It is now widely accepted that a prolonged prodromal phase antedates the onset of 
motor manifestations in sporadic as well as in genetic forms of PD2.   Still while 
clinical abnormalities have been reported in prediagnostic LRRK2-PD3-8, most studies 
suggest that the LRRK2 prodromic phase could be clinically quite silent.  Imaging 
studies are therefore particularly important in the identification of subjects in this 
phase of LRRK2-PD.  
Magnetic resonance imaging (MRI) techniques have demonstrated structural and 
functional abnormalities in asymptomatic LRRK2 mutation carriers8-12.  In structural 
MRI analyses, gray matter (GM) volume increases have been reported in the caudate 
nucleus9 and in the cuneus10, and decreases in the right prefrontal and orbitofrontal 
regions9. Task based functional MRI (fMRI) results in these subjects have shown 
changes in imagery-related activity in different cortical and subcortical brain areas11-
12. Only one study assessed resting state functional connectivity in asymptomatic 
LRRK2 mutation carriers by means of functional MRI (fMRI)13. In this study, 
asymptomatic LRRK2 mutation carriers showed reduced interaction between the right 
inferior parietal cortex and the dorsoposterior putamen but also an increased 
interaction of this cortical area with the ventroanterior putamen, suggesting a 




The aim of the current work was to evaluate whole-brain resting-state functional 
connectivity and structural brain measures in a group of asymptomatic LRRK2 
mutation carriers. We hypothesized that functional nigral and striatal connectivity 
might be altered in this group of subjects at high risk of developing PD, a reflection of 
underlying subclinical brain dysfunction. We also hypothesized that LRRK2 mutation 






Study participants were recruited consecutively between April 2012 and May 2013 
among first-degree relatives of a previously-identified cohort of LRRK2-PD patients at 
the Movement Disorders Unit, Hospital Clínic de Barcelona. Exclusion criteria were 
presence of parkinsonism, other neurodegenerative disorders, and general exclusion 
criteria for MRI scanning (such as claustrophobia or pacemakers). Thirty-six first-
degree relatives of LRRK2-PD patients, who came from 17 families, agreed to 
participate in the study. The presence of a LRRK2 gene mutation, assessed as 
previously described14, was identified in 18 subjects. Among them, 13 (72.2%) were 
carriers of the G2019S, three (16.7%) of the R1441G, and two (11.1%) of the R1441C 
mutations. Participants were not aware of their genetic status at the time of the study.  
 





The study was approved by the Ethics Committee of Hospital Clínic de Barcelona 
(May 2012; code 7723). Written informed consent was obtained from all subjects 




All study participants were clinically evaluated at a single center by the same 
researcher team (DV, ET, and CP). Motor signs were assessed through the Movement 
Disorders Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS-III)15. 
None of the participants showed signs of parkinsonism as determined by neurological 
examination at the time of the study. Smell was evaluated by means of the 40-item 
University of Pennsylvania Smell Identification Test (UPSIT; Smell Identification 
TestTM, Sensonics, Spanish version)16. The Hospital Anxiety and Depression scale 
(HADS)17 and the Beck Depression Inventory-II18 were used to quantify depression 
and anxiety symptoms. Dysautonomic features were assessed by means of the 
SCOPA-AUT scale19. Global cognitive function was tested by the Mini-Mental State 
Examination (MMSE)20. 
 
Statistical analyses of demographic and clinical data 
Normality of distribution of quantitative variables was assessed with the Kolmogorov-
Smirnov test. Normally distributed variables were analyzed using independent-
samples Student’s t tests and Pearson’s product-moment correlations; otherwise, 
Mann-Whitney’s U tests and Spearman’s rank correlations were used. Qualitative 




analyses were performed with SPSS version 18.0 (SPSS Inc.) with a two-sided type I 
error threshold of 5%.  
 
MRI acquisition, processing and analyses 
 
Images for all subjects were obtained with a 3T MRI scanner (MAGNETOM Trio, 
Siemens, Germany), using an 8-channel head coil. The scanning protocol included a 
resting-state, 10-min-long functional gradient-echo echo-planar imaging sequence 
(300 T2*-weighted volumes, TR=2 s, TE=19 ms, flip angle=90º, slice thickness=3 
mm, FOV=240 mm, 128x128 matrix), in which subjects were instructed to keep their 
eyes closed, not to think of anything in particular and not to fall asleep; a high-
resolution 3D structural T1-weighted MPRAGE sequence acquired sagittally (TR=2.3 
s, TE=2.98 ms, 240 slices, FOV=256 mm; 1 mm isotropic voxel), and a T2-weighted 
axial FLAIR sequence (TR=9 s and TE=96 ms). 
 
Cortical thickness  
The processing pipeline for cortical thickness analyses with FreeSurfer (version 5.3; 
available at: http://surfer.nmr.harvard.edu) is provided as supplemental data. 
Comparisons between groups were performed using a vertex-by-vertex general linear 
model using Qdec. An initial vertex-wise threshold was set at p<0.05 to find clusters. 
To avoid false positives, Monte Carlo simulation with 10,000 repeats was performed. 






Subcortical volumes, including putamen, caudate, and estimated total intracranial 
volume (eTIV), were obtained automatically via whole-brain segmentation with 
FreeSurfer.21  
 
Voxel-based morphometry  
Structural data was analyzed with FSL-VBM22, a voxel-based morphometry (VBM) 
style analysis carried out with FSL (release 5.0.4, 
http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSL) (see Supplementary Materials). Voxelwise 
general linear model was applied, and statistical significance was established through 
permutation testing (5,000 permutations), randomizing the study groups and 
generating a sampling distribution of GM volume differences, against which the actual 
group differences were compared. Statistical significance was set at p<0.05, corrected 
for multiple comparisons using family-wise error (FWE) control.  
 
Processing of fMRI  
The preprocessing of resting-state images was performed with FSL and AFNI 
(http://afni.nimh.nih.gov/afni) tools. Briefly, it included removal of the first 5 volumes 
to allow for T1 equilibration, grandmean scaling, linear trend removal and temporal 
filtering (0.01- 0.1 Hz). To control for the effect of head movement and other 
nonneural sources of signal variation, motion correction and regression of nuisance 
signals (six motion parameters, cerebrospinal fluid, and white matter) were performed. 
To remove the effects of timepoints corrupted by motion, a scrubbing procedure23 was 
applied, using a root-mean-square interframe intensity difference threshold equal to 




calculated as the average Euclidean displacement between consecutive timepoints for 
rotatory and translatory motion24. 
 
Definition of regions of interest and extraction of temporal courses 
Structures used as regions of interest (ROIs) for seed-based functional connectivity 
analyses included the substantia nigra and striatum. The striatum was divided into (left 
and right) caudal motor, rostral motor, executive and limbic regions using the Oxford-
GSK-Imanova Striatal Connectivity Atlas 
(http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/Atlases/striatumconn). Supplementary data 
includes an analysis of thalamic functional connectivity. 
 
To define the substantia nigra, motion-corrected individual resting-state data sets were 
temporally averaged and normalized to an MNI template at 2-mm resolution. These 
normalized images were averaged across subjects, and left and right nigral masks 
were manually drawn by a trained radiologist (HB) based on the mean image. 
Supplementary Figure 1 displays the ROI segmentation scheme used.  
 
To obtain each seed region’s resting-state time series, their respective masks were 
linearly registered to each subject’s T1-weighted image, and subsequently linearly 
registered to native functional space using FSL FLIRT. In order to obtain region-
specific temporal courses, we initially thresholded each probabilistic mask at 30%, 
and subsequently extracted a weighted mean of the time series of all voxels inside 
them in native space, without smoothing.  
 




Each seed region’s time course was correlated with the time series of every brain 
voxel using smoothed (6-mm FWHM Gaussian kernel) functional images normalized 
to MNI space after resampling to 4x4x4 mm3 voxel size, producing a Pearson’s r 
coefficient correlation map. These were then converted to Z maps using Fisher’s r-to-
Z transformation. Voxelwise general linear model was applied using non-parametric 
testing including all brain voxels. Statistical significance was established through 
permutation testing (5,000 permutations). Significance level was set at p<0.05 using 
threshold-free cluster enhancement25, corrected for multiple comparisons by 
controlling the family-wise error (FWE) across space. 
 
In order to assess the relationship between functional connectivity alterations and both 
clinical and volumetric data, mean connectivity values were obtained by averaging 
individual Z values in all voxels inside the clusters of significant intergroup 
differences if results contained more than 10 voxels. Pearson correlation was then 
used to correlate these values with age, UPDRS-III and UPSIT scores. Additionally, 
partial correlations were used to correlate age and connectivity values with striatal 
volumes obtained with FreeSurfer, taking eTIV into account.  
 
Image analysis was performed by independent investigators (BS and HB) blinded to 










Demographic and clinical data  
Mean age was similar between mutation carriers and noncarriers, with similar ranges 
(27 to 66 years and 23 to 67 years, respectively) (Table 1). All participants were right-
handed. No significant group differences were found in years of education, or UPDRS 
(I, II or III) and UPSIT scores. Likewise, no significant differences in scores were 
found for other non-motor features.  
 
Functional connectivity  
Asymptomatic LRRK2 mutation carriers showed differences in functional connectivity 
compared with asymptomatic noncarriers. Specifically, we found LRRK2 mutation 
carriers to have reduced connectivity between the caudal motor subdivision of the left 
striatum (including the caudal portions of the putamen and caudate nucleus) and the 
ipsilateral precuneus and superior parietal lobule (p<0.05, FWE-corrected) (see Table 
2 and Figure 1). LRRK2 mutation carriers also displayed reduced functional 
connectivity between the executive subdivision of the left striatum and the anterior-
medial part of the superior frontal gyrus (MNI coordinates 6, 54, 24; cluster size 448 
mm3; p=0.036, FWE-corrected). 
 
Compared with noncarriers, LRRK2 mutation carriers showed increased functional 
connectivity between the right substantia nigra and the occipital pole and cuneus 
bilaterally, and the right lateral occipital cortex (Table 2 and Figure 1).  
 
LRRK2 mutation carriers also displayed reduced functional connectivity between the 




occipital pole, calcarine cortex, lateral occipital cortex and lingual gyrus, and the left 
superior parietal lobule (see supplementary material). Functional connectivity in 
mutation carriers was also reduced between the temporal part of the left thalamus and 
bilateral dorsomedial portions of the precentral gyrus, postcentral gyrus and 
supplementary motor area (see Supplementary Figure 3).  
 
No other significant functional connectivity changes were found when other seed 
regions were tested. No significant differences in head motion were observed between 
LRRK2 mutation carriers and noncarriers (rotation (degrees): carriers 0.03 ± 0.01, 
noncarriers 0.03 ± 0.02, p=0.662; translation (mm): carriers 0.07 ± 0.03, noncarriers: 
0.06 ± 0.05; p=0.445). 
 
Comparisons between G2019S mutation carriers and LRRK2 mutation noncarriers 
Structural and functional intergroup analyses excluding the five subjects with LRRK2 
mutations other than G2019S were performed. Thirteen G2019S carriers were 
contrasted with 18 noncarriers. Functional analyses showed that G2019S mutation 
carriers had reduced connectivity between the caudal motor subdivision of the left 
striatum and both the left precuneus and the superior parietal lobule (Figure 2). 
 
G2019S mutation carriers also displayed increased connectivity of the right substantia 
nigra with the occipital pole and calcarine cortex bilaterally, and with the right lateral 





Differences in thalamic functional connectivity between G2019S mutation carriers 
and LRRK2 mutation noncarriers were similar to those observed between overall 
LRRK2 mutation carriers and noncarriers (see Supplementary Figure 3). 
 
Correlation between functional connectivity, clinical and structural data 
 
In the carrier group, age significantly correlated with mean connectivity Z scores in 
the clusters of significant intergroup differences in left caudal motor striatal 
connectivity (r=-0.475, p=0.046). This effect was not observed in the noncarrier group 
(r=-0.356, p=0.147).  
 
Techniques such as the Bonferroni method for FWE control involving highly 
correlated measures (e.g., basal ganglia volumes) can be excessively conservative26. 
We accordingly assessed a possible correlation between connectivity and a single 
measure, the mean striatal volume, obtained by averaging putaminal and caudate 
volumes.  We observed a significant correlation between Z scores in the clusters of 
intergroup left caudal motor striatal connectivity differences and this compound 
striatal volume measure in the carrier group, but not in the noncarrier group (see Table 
3 and Figure 1). 
 
Post-hoc correlation analyses between connectivity and volumes of individual striatal 
nuclei also revealed significant effects in LRRK2 mutation carriers. In the carrier 
group, Z scores in the clusters of intergroup left caudal motor striatal connectivity 




significant correlations were observed in the noncarrier group (see Figure 1 and Table 
3). 
No significant correlations were observed between Z scores in the clusters of right 
substantia nigra connectivity and subcortical volumes. Also, no significant 
correlations were observed between mean connectivity (in the regions where 
significant intergroup differences were found) and UPDRS-III or UPSIT scores, either 
in the whole sample or in the noncarrier or carrier subgroups (all p>0.2, uncorrected).  
 
Structural MRI findings  
 
GM volumes (VBM analysis and volumetric measures), cortical thickness measures 
and eTIV did not differ significantly between groups (Supplementary Table 2). Age 
correlated significantly and negatively with striatal volumes in the carrier group 





In the present study, asymptomatic LRRK2 mutation carriers showed resting-state 
functional connectivity reductions between the left striatum and both the ipsilateral 
precuneus and superior parietal lobule, and connectivity increments between the right 
substantia nigra and bilateral occipital cortical regions including the occipital poles 
and cunei, and the ipsilateral lateral occipital cortex. These connectivity reductions 
correlated with striatal volumes. Analyses including only subjects with the G2019S 





In manifest idiopathic PD, reduced corticostriatal functional connectivity has been 
described in previous resting-state fMRI studies in which decreased connectivity 
between the thalamus and sensorimotor cortices, 27 and between the striatum and 
thalamus, midbrain, pons and cerebellum28 was observed. Even in untreated patients 
in early stages of idiopathic PD, decreased functional connectivity of the caudate with 
frontal and insular cortices29 and in mesolimbic-striatal and corticostriatal loops30 has 
been observed.  
 
Information concerning functional connectivity alterations in  asymptomatic LRRK2 
carriers is very limited. In healthy G2019S LRRK2 mutation carriers13 a  resting-state 
study reported the presence of  striatocortical connectivity reorganization. As in the 
current study, connectivity changes between the posterior striatum and the parietal 
cortex consisted of positive correlations in mutation noncarriers and negative ones in 
carriers.  In the present study, the striatal connections showing differences between 
groups were mostly reductions in the functional connectivity in mutation carriers. 
However, for the nigral connectivity differences, an increase in functional 
connectivity was observed, occurring between the right substantia nigra and the 
occipital cortex. Interestingly, increased resting-state functional connectivity between 
the right substantia nigra and the occipital cortex has been described in patients with 
idiopathic REM sleep behavior (IRBD) disorder31, a condition considered to represent 
prodromal PD32. As most IRBD patients are eventually diagnosed with a 
synucleinopathy, especially PD32, our findings may represent connectivity changes in 
prediagnostic PD. In the present study, the striatal connections showing differences 




noncarriers. For the nigral connectivity differences, the opposite pattern was observed. 
Although the biological significance of negative correlations is controversial33, 
different studies revealed that the brain activity is organized into anticorrelated 
functional networks34. The nigral and striatal connectivity alterations observed in our 
study might reflect a reorganization of these network dynamics, as previously 
described in patients with idiopathic PD. 35 
 
In line with our findings in prediagnostic PD, changes in functional connectivity in the 
have been found in the prediagnostic phase of other neurodegenerative disorders. In 
Alzheimer’s, decreased functional connectivity occurs mainly between the precuneus 
and limbic regions36. In preclinical Huntington’s disease, weakened and strengthened 
connectivity has been observed in the frontostriatal network, thalamus, anterior insula, 
and memory centers37. Although the meaning of these functional changes is unclear, 
our results suggest that the neurodegenerative process has already started in some of 
these mutation carriers, leading to brain connectivity changes. 
 
No significant GM atrophy was detected in our asymptomatic mutation carriers, either 
with VBM or a more sensitive technique such as cortical thickness analysis38,39. 
Correlation analyses, nonetheless, showed that mutation carriers with more marked 
striatal connectivity reductions tended to have lower striatal volumes, suggesting that 
LRRK2 mutation carriers with the lowest levels of striatal connectivity already display 
subtle signs of neurodegeneration. As LRRK2 mutation penetrance is age-dependent3, 
this hypothesis is in line with the correlation observed between age and both striatal 
connectivity and striatal volumes in the carrier group. It cannot be ruled out, however, 




volumes) can be at least partially explained by the effect of LRRK2 mutations. 
Previous studies showed that the LRRK2 gene is involved in neuronal morphogenesis 
as well as striatal synaptic transmission and synaptogenesis during development40. 
The follow-up of these subjects is critical to determine if the observed connectivity 
reductions or smaller subcortical volumes can predict the occurrence of LRRK2-PD. It 
is difficult to provide an explanation for the laterality of the functional connectivity 
changes observed in our study. Prospective studies in asymptomatic LRRK2 mutation 
carriers may also  inform  whether the  connectivity findings observed reflect the 
typical asymmetrical pattern of PD initiation and  progression.   
 
The small sample size, the lack of behavioral and cognitive assessments, as well as the 
inclusion of subjects with different LRRK2 mutations, potentially with different 
underlying neuropathological substrates, represent  limitations when interpreting our 
results. Similarly, our study did not include either healthy controls unrelated to 
LRRK2-PD patients or a group of symptomatic LRRK2-PD patients for comparison 
purposes. The inclusion of functional and structural analyses can be considered 
strengths to this study. Structural connectivity techniques could help clarify in future 
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Age, years 43.33 ± 12.07 44.72 ± 12.48 0.339/0.736 
Gender, % male 9 (50%) 7 (38.9%) 0.450χ/0.502 
Mutation, n (%) 
    G2019S 
    R1441C 








Years of education 13.44 ± 5.08 15.28 ± 4.66 1.128/0.267 
UPDRS I score 2.89 ± 4.52 2.39 ± 3.70 157.5§/0.881 
UPDRS II score 0.22 ± 0.43 0.28 ±0.58 160.0§/0.930 
UPDRS III score 0.39 ± 0.98 0.06 ±0.24 134.5§/0.147 
UPSIT score 32.72 ± 3.74 33.0 ± 3.45 0.232/0.818 
SCOPA-AUT score 8.44 ± 6.68 7.56 ± 4.88 0.456/0.651 
HADS total score 8.0 ± 5.69 7.83 ± 6.05 0.085/0.933 
HADS Anxiety score 5.17 ± 3.26 5.39 ± 3.24 0.205/0.839 
HADS Depression score 2.83 ± 2.68 2.44 ± 3.37 0.383/0.704 
BDI 5.12 ± 6.19 4.06 ± 4.87 0.566/0.575 





Results are described by mean ± SD. Test statistics (Test stat) refer to Student’s t, 
Mann-Whitney’s U (§) or Pearson’s chi-square (χ).  
BDI: Beck Depression Inventory-II. HADS: Hospital Anxiety and Depression Scale. 
MMSE: Mini-mental state examination. SCOPA-AUT: Scales for Outcomes in 
Parkinson's disease – Autonomic. UPDRS: unified Parkinson’s disease rating scale. 























Table 2.  Differential connectivity in asymptomatic LRRK2 mutation carriers and 
noncarriers.   
 
Topography (maximum)  
Volume  
(mm3) 
Voxels MNI coordinates p-value 
Right substantia nigra seed 
Right occipital pole 9344 146 14, -94, 20 0.003 
Right occipital pole 768 12 26, -94, -12 0.008 
Right lateral occipital cortex 640 10 46, -62, 8 0.037 
Right lateral occipital cortex 576 9 50, -78, -16 0.038 
Left striatum, caudal motor region seed 
Superior parietal lobule 2368 37 -30, -70, 52 0.019 
Precuneus 1728 27 -6, -58, 60 0.013 
 
Description of clusters of significant between-group functional connectivity 
differences (p<0.05 FWE-corrected). Asymptomatic LRRK2 mutation carriers showed 
reduced left striatocortical and increased right nigrocortical connectivity compared 










Table 3. Correlations between subcortical volumes and both age and connectivity 
measures. 
 
















0.63/0.007 0.05/0.842 -0.67/0.003 -0.23/0.382 
L caudate 0.65/0.004 0.07/0.801 -0.54/0.024 -0.14/0.592 
L putamen 0.53/0.029 0.05/0.861 -0.65/0.005 -0.21/0.425 
R caudate 0.61/0.010 -0.01/0.997 -0.52/0.031 -0.2/0.442 
R putamen 0.57/0.018 0.07/0.805 -0.68/0.003 -0.24/0.354 
 
Left caudal motor striatal connectivity: mean Z scores in the clusters of significant 
intergroup differences in connectivity with the caudal motor subdivision of the left 
striatum. Mean striatal volume: average of bilateral caudate and putaminal volumes. 












Fig 1. Differential resting-state functional connectivity between asymptomatic 
LRRK2 mutation carriers and noncarriers and correlations with striatal volumes. 
Panels A and B: Color clusters indicate areas of significant increases in connectivity 
of the right substantia nigra (panel A) and connectivity reductions of the caudal motor 
subdivision of the left striatum (panel B) in mutation carriers (p<0.05, FWE 
correction). Plots show the distribution of mean connectivity values in the regions 
where significant intergroup differences were found, according to group. The 
Montreal Neurological Institute coordinates of the slices shown are indicated. Panels 
C and D: Plots show the relationship between connectivity levels (in the clusters 
shown in panel B) and striatal volumes (panel C: mean striatal volume; panel D: right 
and left caudate nuclei and putamina). Significant correlations were observed in the 




carriers are represented by gray circles; mutation noncarriers are indicated by green 
triangles. 
 
Fig 2. Differential resting-state functional connectivity between asymptomatic 
G2019S LRRK2 mutation carriers and noncarriers.  
Color clusters indicate areas of significant increments in connectivity of the right 
substantia nigra (panel A) and connectivity reductions of the caudal motor subdivision 
of the left striatum (panel B) in mutation carriers (p<0.05, FWE correction). Plots 
show the distribution of mean connectivity values in the regions where significant 
intergroup differences were found, according to group. LRRK2 mutation carriers are 
represented by gray circles; mutation noncarriers are indicated by green triangles. The 
Montreal Neurological Institute coordinates of the slices shown are indicated. R: right. 
L: left. P: posterior.  
 
 
 
 
 
 
 
 
 31 
 
 
 
 
 
